Trial Profile
The Study of INitial choice of DPP-4i in Japanese T2DM patients: Effects of Linagliptin on QOL
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Mar 2019
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INTEL-QOL
- 04 Jan 2019 Status changed from active, no longer recruiting to completed.
- 01 Jun 2018 Trial design and protocol, published in the Diabetes Therapy Journal.
- 03 Mar 2018 Status changed from recruiting to active, no longer recruiting.